The former chief executive of Vascular Solutions beat federal charges
of off-label use. Now he discusses his next move, and why government
oversight is hampering the medical device industry.
Health Care + Med Tech
Most hospitals are not fully prepared to handle low-weight births.
Second early-stage trial of ‘remyelinating’ drug candidate is close to completion.
The Center for Drug Design research team is readying "Sulfanegen" for clinical trials.
St. Cloud’s city administrator called the city council’s current version of the ordinance a “hybrid” of its existing law and of what had been enacted in Edina.
Report says employees paid record 31% of annual premium for family benefits.
New collaboration is clinic’s second in emerging personalized wellness field.
CHI St. Gabriel’s Health to outline program for Congress.
The hip eyewear company previously didn't accept vision insurance.
CSI shares hit a six-month low after it warned Harvey and Irma will have a negative impact on quarterly sales guidance.
Instead of prescribing an opioid-based treatment plan, the Intellis system offers doctors a non-opioid approach to treating chronic back pain.
The biotechnology company officially kicked off its IPO on Wednesday.
The startup’s personalized medicine test offers a unique potential in Asia, where people take similar medications to Americans and Europeans but don’t share the same genetic makeup.
The deal, according to an analyst at Leerink, would cost the Minnetonka-based insurer roughly $2.8 billion if completed.
U of M spinoff has tech to analyze microbial communities for health, ag clients.
Manufactured ‘XNA’ can bind to proteins that regulate cardiac function.
Percentage of state residents without health coverage less than half the national rate.
But he called the goal of single payer an "aspirational" one.